Review
Copyright ©The Author(s) 2022.
World J Orthop. Jan 18, 2022; 13(1): 11-35
Published online Jan 18, 2022. doi: 10.5312/wjo.v13.i1.11
Table 4 Clinical presentation and management of local anesthetic systemic toxicity
Local anesthetic systemic toxicity (LAST)
Clinical presentation of LAST
1 Dizziness, drowsiness, tinnitus, perioral numbness
2 Muscle twitching and tremors
3 Seizures
4 CNS depression, coma
5 Hypertension, tachycardia
6 Myocardial depression, ventricular arrhythmias, conduction delays
7 EKG changes: Prolonged PR, QRS; T-wave changes
8 Cardiovascular collapse
Management of LAST
1 Call for help
2 Call for LAST rescue kit
3 Consider early lipid emulsion administration
(1) Under 70 kg: Bolus 1.5 mL/kg over 2-3 min, Infuse 0.25 mL/kg/min. Repeat bolus or double the infusion rate if the patient remains unstable
(2) Over 70 kg: Bolus approximately 100 mL over 2-3 min, infuse approximately 250 mL over 15-20 min. Repeat bolus or double the infusion rate if the patient remains unstable
(3) If the patient is stable, continue lipid emulsion ≥ 15 min after hemodynamic stability. Maximum lipid dose: 12 mL/kg
4 Seizure
(1) Airway management
(2) Benzodiazepine
(3) Consider low dose propofol
5 Arrhythmia or cardiovascular Instability
(1) Epinephrine: Administered at lower dose than ACLS dosing, start with ≤ 1 mcg/kg
(2) Avoid local anesthetics, beta-blockers, vasopressin, calcium channel blockers
(3) Consider alerting cardiopulmonary bypass team
6 Close monitoring
Once stable, continue close monitoring: 2 h after seizure, 4-6 h after cardiovascular instability, and as clinically appropriate after cardiac arrest